Annual report pursuant to Section 13 and 15(d)

Geographic information - Major Customers (Details)

v3.22.0.1
Geographic information - Major Customers (Details) - Revenues - Customer Concentration Risk
12 Months Ended
Dec. 31, 2021
Astellas Pharma Inc.  
Major Customers  
Concentration risk (as a percentage) 63.00%
GlaxoSmithKline Intellectual Property Development Ltd  
Major Customers  
Concentration risk (as a percentage) 36.00%